Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Joint Modeling of Primary and Secondary Non-Adherence Outcomes.

Pedan A, Geng J.

Value Health. 2014 Nov;17(7):A752. doi: 10.1016/j.jval.2014.08.205. Epub 2014 Oct 26. No abstract available.

2.

A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients.

Moran J, Sun S, Khababa I, Pedan A, Doss S, Schiller B.

Am J Kidney Dis. 2012 Jan;59(1):102-7. doi: 10.1053/j.ajkd.2011.08.031. Epub 2011 Nov 14.

PMID:
22088576
3.

Survey nonresponders to a medication-beliefs survey have worse adherence and persistence to chronic medications compared with survey responders.

Gadkari AS, Pedan A, Gowda N, McHorney CA.

Med Care. 2011 Oct;49(10):956-61. doi: 10.1097/MLR.0b013e3182204503.

PMID:
21666513
4.
5.

The role of patient inexperience in medication discontinuation: a retrospective analysis of medication nonpersistence in seven chronic illnesses.

Vanelli M, Pedan A, Liu N, Hoar J, Messier D, Kiarsis K.

Clin Ther. 2009 Nov;31(11):2628-52. doi: 10.1016/j.clinthera.2009.11.028.

PMID:
20110007
6.

Assessment of drug consumption patterns for Medicare Part D patients.

Pedan A, Lu J, Varasteh LT.

Am J Manag Care. 2009 May;15(5):323-7.

7.

The effect of Medicare Part D coverage on drug use and cost sharing among seniors without prior drug benefits.

Schneeweiss S, Patrick AR, Pedan A, Varasteh L, Levin R, Liu N, Shrank WH.

Health Aff (Millwood). 2009 Mar-Apr;28(2):w305-16. doi: 10.1377/hlthaff.28.2.w305. Epub 2009 Feb 3.

8.

The effect of transitioning to medicare part d drug coverage in seniors dually eligible for medicare and medicaid.

Shrank WH, Patrick AR, Pedan A, Polinski JM, Varasteh L, Levin R, Liu N, Schneeweiss S.

J Am Geriatr Soc. 2008 Dec;56(12):2304-10. doi: 10.1111/j.1532-5415.2008.02025.x.

10.

Adherence and persistence with fluticasone propionate/salmeterol combination therapy.

Bender BG, Pedan A, Varasteh LT.

J Allergy Clin Immunol. 2006 Oct;118(4):899-904. Epub 2006 Sep 8.

PMID:
17030244
11.

Efficacy and safety results with the LifeSite hemodialysis access system versus the Tesio-Cath hemodialysis catheter at 12 months.

Rosenblatt M, Caridi JG, Hakki FZ, Jackson J, Kapoian T, Martin SP, Moran J, Pedan A, Reese WJ, Ross JP, Ross J, Rushton F, Schwab SJ, Soundararajan R, Stainken B, Weiss MA, Work J, Yegge J.

J Vasc Interv Radiol. 2006 Mar;17(3):497-504.

PMID:
16567674
12.

End-stage renal disease-associated managed care costs among patients with and without diabetes.

Joyce AT, Iacoviello JM, Nag S, Sajjan S, Jilinskaia E, Throop D, Pedan A, Ollendorf DA, Alexander CM.

Diabetes Care. 2004 Dec;27(12):2829-35.

PMID:
15562193
13.

Evaluation of a monthly coverage maximum (drug-specific quantity limit) on the 5-HT1 agonists (triptans) and dihydroergotamine nasal spray.

Hoffman L, Mayzell G, Pedan A, Farrell M, Gilbert T.

J Manag Care Pharm. 2003 Jul-Aug;9(4):335-45.

14.

Sinus versus nonsinus tachycardia in the emergency department: importance of age and heart rate.

Pinto DS, Ho KK, Zimetbaum PJ, Pedan A, Goldberger AL.

BMC Cardiovasc Disord. 2003 Aug 5;3:7. Epub 2003 Aug 5.

15.

Multicenter clinical trial results with the LifeSite hemodialysis access system.

Schwab SJ, Weiss MA, Rushton F, Ross JP, Jackson J, Kapoian T, Yegge J, Rosenblatt M, Reese WJ, Soundararajan R, Work J, Ross J, Stainken B, Pedan A, Moran JA.

Kidney Int. 2002 Sep;62(3):1026-33.

16.

Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness.

Van Eerdewegh P, Little RD, Dupuis J, Del Mastro RG, Falls K, Simon J, Torrey D, Pandit S, McKenny J, Braunschweiger K, Walsh A, Liu Z, Hayward B, Folz C, Manning SP, Bawa A, Saracino L, Thackston M, Benchekroun Y, Capparell N, Wang M, Adair R, Feng Y, Dubois J, FitzGerald MG, Huang H, Gibson R, Allen KM, Pedan A, Danzig MR, Umland SP, Egan RW, Cuss FM, Rorke S, Clough JB, Holloway JW, Holgate ST, Keith TP.

Nature. 2002 Jul 25;418(6896):426-30. Epub 2002 Jul 10.

PMID:
12110844
17.

The LifeSite hemodialysis access system: implications for the nephrology nurse.

Haynes BJ, Quarles AW, Vavrinchik J, White J, Pedan A.

Nephrol Nurs J. 2002 Feb;29(1):27-33, 72.

PMID:
11887487
18.

Reducing antibiotic use in children: a randomized trial in 12 practices.

Finkelstein JA, Davis RL, Dowell SF, Metlay JP, Soumerai SB, Rifas-Shiman SL, Higham M, Miller Z, Miroshnik I, Pedan A, Platt R.

Pediatrics. 2001 Jul;108(1):1-7.

PMID:
11433046
19.

Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.

Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, Sugarbaker DJ, Donaldson MC, Poss R, Ho KK, Ludwig LE, Pedan A, Goldman L.

Circulation. 1999 Sep 7;100(10):1043-9.

20.

Cardiac troponin T as a marker for myocardial ischemia in patients seen at the emergency department for acute chest pain.

Johnson PA, Goldman L, Sacks DB, Garcia T, Albano M, Bezai M, Pedan A, Cook EF, Lee TH.

Am Heart J. 1999 Jun;137(6):1137-44.

PMID:
10347343
21.

Health-related quality of life after elective surgery: measurement of longitudinal changes.

Mangione CM, Goldman L, Orav EJ, Marcantonio ER, Pedan A, Ludwig LE, Donaldson MC, Sugarbaker DJ, Poss R, Lee TH.

J Gen Intern Med. 1997 Nov;12(11):686-97.

22.

Troponin T as a marker for myocardial ischemia in patients undergoing major noncardiac surgery.

Lee TH, Thomas EJ, Ludwig LE, Sacks DB, Johnson PA, Donaldson MC, Cook EF, Pedan A, Kuntz KM, Goldman L.

Am J Cardiol. 1996 May 15;77(12):1031-6.

PMID:
8644653

Supplemental Content

Support Center